Anaphylactic reaction to rocuronium bromide.
Department of Anaesthesia, Waikato Hospital, Hamilton, New Zealand.
R
R
Yee
J A
JA
Fernandez
D015746:Abdominal Pain / Q000175:diagnosis; D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced*; D000732:Androstanols / Q000009:adverse effects*; D000906:Antibodies / Q000097:blood; D001986:Bronchial Spasm / Q000139:chemically induced; D053818:Chymases; D004342:Drug Hypersensitivity / Q000209:etiology*; D004487:Edema / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D018836:Inflammation Mediators / Q000097:blood; D010535:Laparoscopy; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D000077123:Rocuronium; D012697:Serine Endopeptidases / Q000097:blood; D012882:Skin Tests; D053802:Tryptases; D014581:Urticaria / Q000139:chemically induced
D000732:Androstanols; D000906:Antibodies; D018836:Inflammation Mediators; D003473:Neuromuscular Nondepolarizing Agents; D007073:Immunoglobulin E; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases; D000077123:Rocuronium